Literature DB >> 34231193

Preparation and Characterization of Co-Processed Mannitol and Sorbitol Using NanoCrySP Technology.

Srilaxmi G Rao1, Prashantkumar K Parmar1, Katangur Vishruth Reddy1, Arvind K Bansal2.   

Abstract

Particle engineering of excipients, at sub-particulate level using co-processing, can provide high functionality excipients. NanoCrySP technology has been recently explored as a novel approach for the generation of nanocrystalline solid dispersion of poorly soluble drugs, using spray drying process. The purpose of the present study was to generate co-processed mannitol and sorbitol (SD-CSM) using NanoCrySP technology having similar composition to commercial co-processed excipient (Compressol® SM, CP). The characterization of excipients was performed to evaluate their various physicomechanical properties. The sub-micron crystallite size of sorbitol in the matrix of mannitol was determined using the Williamson-Hall equation and Halder-Wagner equation. The reduction in crystallite size of sorbitol and mannitol, lower melting point, and lower heat of fusion of SD-CSM could be responsible for excellent compactibility, better tabletability, and comparable compressibility with respect to CP. This was confirmed by the compressibility-tabletability-compactibility (CTC) profile and Heckel plot analysis. Overall, SD-CSM generated using NanoCrySP technology improved functionalities of excipients over CP and would be useful for direct compression application.

Entities:  

Keywords:  NanoCrySP technology; co-processed excipient; compaction; mannitol; sorbitol

Year:  2021        PMID: 34231193     DOI: 10.1208/s12249-021-02071-1

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  17 in total

1.  Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol.

Authors:  A Burger; J O Henck; S Hetz; J M Rollinger; A A Weissnicht; H Stöttner
Journal:  J Pharm Sci       Date:  2000-04       Impact factor: 3.534

Review 2.  Multifunctional coprocessed excipients for improved tabletting performance.

Authors:  Sumit Saha; Aliasgar F Shahiwala
Journal:  Expert Opin Drug Deliv       Date:  2009-02       Impact factor: 6.648

3.  NanoCrySP technology for generation of drug nanocrystals: translational aspects and business potential.

Authors:  Ganesh Shete; Arvind Kumar Bansal
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

4.  Molecular understanding of the compaction behavior of indomethacin polymorphs.

Authors:  Kailas S Khomane; Parth K More; Guru Raghavendra; Arvind K Bansal
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

5.  Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability.

Authors:  Mihir K Raval; Kishor R Sorathiya; Narendra P Chauhan; Jaydeep M Patel; Rajesh K Parikh; Navin R Sheth
Journal:  Drug Dev Ind Pharm       Date:  2012-03-02       Impact factor: 3.225

Review 6.  An Overview of Pharmaceutical Excipients: Safe or Not Safe?

Authors:  Cátia G Abrantes; Dinah Duarte; Catarina P Reis
Journal:  J Pharm Sci       Date:  2016-06-01       Impact factor: 3.534

7.  Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.

Authors:  Chaitali Phadke; Jagadish Sharma; Kunnal Sharma; Arvind K Bansal
Journal:  Mol Pharm       Date:  2019-09-11       Impact factor: 4.939

8.  Polyols as filler-binders for disintegrating tablets prepared by direct compaction.

Authors:  Gerad K Bolhuis; Erik G Rexwinkel; Klaas Zuurman
Journal:  Drug Dev Ind Pharm       Date:  2009-06       Impact factor: 3.225

9.  Spherical crystallization of mebendazole to improve processability.

Authors:  Smiti Kumar; Garima Chawla; Arvind K Bansal
Journal:  Pharm Dev Technol       Date:  2008       Impact factor: 3.133

10.  Coprocessing of nevirapine and stavudine by spray drying.

Authors:  G A Mohammed; Vibha Puri; Arvind Kumar Bansal
Journal:  Pharm Dev Technol       Date:  2008       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.